PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
45.60%
Revenue growth above 1.5x PUK's 27.93%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
402.71%
Gross profit growth above 1.5x PUK's 27.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
3233.53%
EBIT growth above 1.5x PUK's 246.79%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
3233.53%
Operating income growth above 1.5x PUK's 27.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
228.01%
Net income growth under 50% of PUK's 2157.71%. Michael Burry would suspect the firm is falling well behind a key competitor.
346.15%
EPS growth under 50% of PUK's 1749.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
338.46%
Diluted EPS growth under 50% of PUK's 1749.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-28.12%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-27.47%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
527.53%
Positive 10Y revenue/share CAGR while PUK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
166.09%
Positive 5Y CAGR while PUK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
2359.29%
Positive 3Y CAGR while PUK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
729.57%
Net income/share CAGR above 1.5x PUK's 202.69% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.48%
Below 50% of PUK's 835.13%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
41.63%
3Y net income/share CAGR 75-90% of PUK's 48.42%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while PUK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.